O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-9.96%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.16B
AUM Growth
+$6.16B
(-21%)
Cap. Flow
-$479M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
32.31%
Holding
169
New
10
Increased
33
Reduced
25
Closed
28
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$85.3M |
| 2 |
Pfizer
PFE
|
$66.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$60.6M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$54.6M |
| 5 |
argenx
ARGX
|
$53.5M |
Top Sells
| 1 |
Merck
MRK
|
$136M |
| 2 |
Bristol-Myers Squibb
BMY
|
$126M |
| 3 |
HCA Healthcare
HCA
|
$100M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$80.7M |
| 5 |
SVA
Sinovac Biotech, Ltd
SVA
|
$72.7M |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$13.8B
| $82.1M | 1.33% | 875,515 -56,400 | -6% | -$5.29M |
|
27
DexCom
DXCM
$29.5B
| $76.7M | 1.24% | 149,900 -3,000 | -2% | -$1.53M |
|
28
Thermo Fisher Scientific
TMO
$186B
| $71.2M | 1.16% | 120,600 +25,900 | +27% | +$15.3M |
|
29
SI-BONE Inc
SIBN
$719M
| $70.9M | 1.15% | 3,139,247 +833,947 | +36% | +$18.8M |
|
30
Crinetics Pharmaceuticals
CRNX
$2.92B
| $70.2M | 1.14% | 3,196,876 | – | – |
|
31
Prelude Therapeutics
PRLD
$68.5M
| $69.3M | 1.12% | 10,039,691 | – | – |
|
32
Natera
NTRA
$23.1B
| $64.9M | 1.05% | 1,595,385 +181,400 | +13% | +$7.38M |
|
|
SRRA
33
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $63M | 1.02% | 1,964,770 +487,450 | +33% | +$15.6M |
|
|
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $54.6M | 0.89% | +1,576,600 | New | +$54.6M |
|
|
TPTX
35
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $54.2M | 0.88% | 2,018,950 -87,500 | -4% | -$2.35M |
|
36
Tenet Healthcare
THC
$16.3B
| $54M | 0.88% | 628,300 +329,300 | +110% | +$28.3M |
|
|
37
argenx
ARGX
$43.6B
| $53.5M | 0.87% | +169,800 | New | +$53.5M |
|
38
Xtant Medical Holdings
XTNT
$83.3M
| $49.6M | 0.8% | 72,943,918 +70,424 | +0.1% | +$47.9K |
|
39
Repare Therapeutics
RPTX
$71.7M
| $47.3M | 0.77% | 3,322,488 | – | – |
|
40
MeiraGTx Holdings
MGTX
$587M
| $45.7M | 0.74% | 3,296,666 -430,800 | -12% | -$5.97M |
|
|
KNTE
41
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $45.5M | 0.74% | 4,043,629 +195,700 | +5% | +$2.2M |
|
42
Evolent Health
EVH
$1.12B
| $45.2M | 0.73% | 1,400,000 +462,000 | +49% | +$14.9M |
|
43
AbCellera Biologics
ABCL
$1.25B
| $40.8M | 0.66% | 4,180,768 | – | – |
|
44
Janux Therapeutics
JANX
$1.37B
| $40.7M | 0.66% | 2,836,386 | – | – |
|
|
NSTG
45
DELISTED
NanoString Technologies, Inc.
NSTG
| $40.2M | 0.65% | 1,157,387 +350,287 | +43% | +$12.2M |
|
46
Syndax Pharmaceuticals
SNDX
$1.41B
| $37.5M | 0.61% | 2,158,300 +177,000 | +9% | +$3.08M |
|
|
ALPN
47
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $36.6M | 0.59% | 4,081,592 | – | – |
|
48
Vaxcyte
PCVX
$4B
| $36.6M | 0.59% | 1,513,659 +416,959 | +38% | +$10.1M |
|
49
TELA Bio
TELA
$70.5M
| $35.2M | 0.57% | 3,027,542 | – | – |
|
50
Neuropace
NPCE
$303M
| $32.9M | 0.53% | 4,012,281 | – | – |
|